Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Colorado Retina Associates, Lakewood, Colorado Ophthalmic Consultants of Boston, East Weymouth, Massachusetts Austin Retina Associates, Austin, Texas Retina Consultants Texas, The Woodlands, Texas